These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17192644)

  • 21. Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry.
    Indurthi DC; Qudah T; Liao VW; Ahring PK; Lewis TM; Balle T; Chebib M; Absalom NL
    Pharmacol Res; 2019 Jan; 139():215-227. PubMed ID: 30472464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.
    Wu J; Liu Q; Yu K; Hu J; Kuo YP; Segerberg M; St John PA; Lukas RJ
    J Physiol; 2006 Oct; 576(Pt 1):103-18. PubMed ID: 16825297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rare human nicotinic acetylcholine receptor α4 subunit (CHRNA4) variants affect expression and function of high-affinity nicotinic acetylcholine receptors.
    McClure-Begley TD; Papke RL; Stone KL; Stokes C; Levy AD; Gelernter J; Xie P; Lindstrom J; Picciotto MR
    J Pharmacol Exp Ther; 2014 Mar; 348(3):410-20. PubMed ID: 24385388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits.
    Gotti C; Moretti M; Meinerz NM; Clementi F; Gaimarri A; Collins AC; Marks MJ
    Mol Pharmacol; 2008 Jun; 73(6):1796-807. PubMed ID: 18337473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric Modulator.
    Hamouda AK; Deba F; Wang ZJ; Cohen JB
    Mol Pharmacol; 2016 May; 89(5):575-84. PubMed ID: 26976945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The additional ACh binding site at the α4(+)/α4(-) interface of the (α4β2)2α4 nicotinic ACh receptor contributes to desensitization.
    Benallegue N; Mazzaferro S; Alcaino C; Bermudez I
    Br J Pharmacol; 2013 Sep; 170(2):304-16. PubMed ID: 23742319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The (
    DeDominicis KE; Sahibzada N; Olson TT; Xiao Y; Wolfe BB; Kellar KJ; Yasuda RP
    Mol Pharmacol; 2017 Sep; 92(3):327-337. PubMed ID: 28698187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying the binding site of novel methyllycaconitine (MLA) analogs at α4β2 nicotinic acetylcholine receptors.
    Quek GX; Lin D; Halliday JI; Absalom N; Ambrus JI; Thompson AJ; Lochner M; Lummis SC; McLeod MD; Chebib M
    ACS Chem Neurosci; 2010 Dec; 1(12):796-809. PubMed ID: 22778816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rat nicotinic ACh receptor alpha7 and beta2 subunits co-assemble to form functional heteromeric nicotinic receptor channels.
    Khiroug SS; Harkness PC; Lamb PW; Sudweeks SN; Khiroug L; Millar NS; Yakel JL
    J Physiol; 2002 Apr; 540(Pt 2):425-34. PubMed ID: 11956333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural and functional studies of the modulator NS9283 reveal agonist-like mechanism of action at α4β2 nicotinic acetylcholine receptors.
    Olsen JA; Ahring PK; Kastrup JS; Gajhede M; Balle T
    J Biol Chem; 2014 Sep; 289(36):24911-21. PubMed ID: 24982426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinctive effects of nicotinic receptor intracellular-loop mutations associated with nocturnal frontal lobe epilepsy.
    Weltzin MM; Lindstrom JM; Lukas RJ; Whiteaker P
    Neuropharmacology; 2016 Mar; 102():158-73. PubMed ID: 26561946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors.
    Zwart R; Carbone AL; Moroni M; Bermudez I; Mogg AJ; Folly EA; Broad LM; Williams AC; Zhang D; Ding C; Heinz BA; Sher E
    Mol Pharmacol; 2008 Jun; 73(6):1838-43. PubMed ID: 18367540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AE Succinimide, an Analogue of Methyllycaconitine, When Bound Generates a Nonconducting Conformation of the α4β2 Nicotinic Acetylcholine Receptor.
    Qudah T; Quek GX; Indurthi D; Karim N; Halliday JI; Absalom N; McLeod MD; Chebib M
    ACS Chem Neurosci; 2020 Feb; 11(3):344-355. PubMed ID: 31898891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering α4β2 nAChRs with reduced or increased nicotine sensitivity via selective disruption of consensus sites in the M3-M4 cytoplasmic loop of the α4 subunit.
    Biaggi-Labiosa NM; Avilés-Pagán E; Caballero-Rivera D; Báez-Pagán CA; Lasalde-Dominicci JA
    Neuropharmacology; 2015 Dec; 99():273-84. PubMed ID: 25957813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human alpha4beta2 acetylcholine receptors formed from linked subunits.
    Zhou Y; Nelson ME; Kuryatov A; Choi C; Cooper J; Lindstrom J
    J Neurosci; 2003 Oct; 23(27):9004-15. PubMed ID: 14534234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleep-related hypermotor epilepsy associated mutations uncover important kinetic roles of α4β2- nicotinic acetylcholine receptor intracellular structures.
    Weltzin MM; George AA; Lukas RJ; Whiteaker P
    PLoS One; 2021; 16(3):e0247825. PubMed ID: 33657187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chaperone protein 14-3-3 and protein kinase A increase the relative abundance of low agonist sensitivity human alpha 4 beta 2 nicotinic acetylcholine receptors in Xenopus oocytes.
    Exley R; Moroni M; Sasdelli F; Houlihan LM; Lukas RJ; Sher E; Zwart R; Bermudez I
    J Neurochem; 2006 Aug; 98(3):876-85. PubMed ID: 16787419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unorthodox Acetylcholine Binding Sites Formed by α5 and β3 Accessory Subunits in α4β2* Nicotinic Acetylcholine Receptors.
    Jain A; Kuryatov A; Wang J; Kamenecka TM; Lindstrom J
    J Biol Chem; 2016 Nov; 291(45):23452-23463. PubMed ID: 27645992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Covalent trapping of methyllycaconitine at the α4-α4 interface of the α4β2 nicotinic acetylcholine receptor: antagonist binding site and mode of receptor inhibition revealed.
    Absalom NL; Quek G; Lewis TM; Qudah T; von Arenstorff I; Ambrus JI; Harpsøe K; Karim N; Balle T; McLeod MD; Chebib M
    J Biol Chem; 2013 Sep; 288(37):26521-32. PubMed ID: 23893416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unraveling amino acid residues critical for allosteric potentiation of (α4)3(β2)2-type nicotinic acetylcholine receptor responses.
    Wang ZJ; Deba F; Mohamed TS; Chiara DC; Ramos K; Hamouda AK
    J Biol Chem; 2017 Jun; 292(24):9988-10001. PubMed ID: 28446611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.